August 16, 2022 8:00am EDT QSAM Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
July 13, 2022 1:32pm EDT QSAM Biosciences Receives Third U.S. Patent for Clinical-Stage Radiopharmaceutical Drug Candidate CycloSam®
